Herbas VPB

Print
EN | LT
LT - Daugybinės mielomos, naudojant kombinuotas terapijas, pagrįstas HuLuc63 su bortezomibu, gydymo būdai
EN - Methods of treating multiple myeloma using combination therapies based on HuLuc63 with bortezomib

Legal status

Patent in force

Claims | Licences
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/573 (2006.01)
A61K 31/454 (2006.01)
A61K 31/69 (2006.01)
A61K 39/395 (2006.01)
A61P 35/00 (2006.01)
A61K 45/06 (2006.01)
European patent
(11) Number of the document 2641601
(13) Kind of document T
(96) European patent application number 13168383.1
Date of filing the European patent application 2007-08-07
(97) Date of publication of the European application 2013-09-25
(45) Date of publication and mention of the grant of the patent 2016-07-06
(46) Date of publication of the claims translation 2016-10-10
Priority applications
(30) Number Date Country code
836185 P 2006-08-07 US
944262 P 2007-06-15 US
Inventors
(72)
Afar, Daniel, US
Andersen, Kenneth C., US
Tai, Yu-Tzu, US
Grantee
(73) AbbVie Biotherapeutics Inc., 1500 Seaport Boulevard, Redwood City, CA 94063, US
Dana-Farber Cancer Institute, Inc., 450 Brookline Avenue, Boston, MA 02215, US
Attorney or representative
(74) Liucija JANICKAITĖ, Inpatra UAB, Šeškinės g. 59-53, LT-07162 Vilnius, LT
Title
(54) Daugybinės mielomos, naudojant kombinuotas terapijas, pagrįstas HuLuc63 su bortezomibu, gydymo būdai
  Methods of treating multiple myeloma using combination therapies based on HuLuc63 with bortezomib
Last renewal fee
Payment date Validity (years) Amount
2025-07-10 19 347.00 EUR
Next renewal fee
2026-08-07
Last update date 2025-07-11